Patents by Inventor Ebo Bos

Ebo Bos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PAN-REACTIVE ANTIBODIES TO DUOCARMYCINS
    Publication number: 20170320965
    Abstract: The present invention relates to a monoclonal, pan-reactive antibody to duocarmycins. The monoclonal, pan-reactive antibody of the present invention may be used to detect, isolate and/or quantify a duocarmycin-containing antibody-drug conjugate in a biological or non biological sample, for example using an immunoassay.
    Type: Application
    Filed: September 22, 2015
    Publication date: November 9, 2017
    Applicant: SYNTHON BIOPHARMACEUTICALS B.V.
    Inventors: David EGGING, Patrick Henry BEUSKER, Ellen MATTAAR, Ebo BOS
  • Tumor associated epitope
    Patent number: 5951985
    Abstract: This invention relates to the epitopes to which monoclonal antibody 88BV59 and antibody 16.88 react. These antibodies were produced by B-cell lines derived from B-cells of cancer patients actively immunized with autologous tumor antigens. Both epitopes are found on the same antigen in tumor tissue. These epitopes can be used in both diagnostic procedures and therapy for human cancers.
    Type: Grant
    Filed: August 19, 1997
    Date of Patent: September 14, 1999
    Assignee: Perimmune Holdings, Inc.
    Inventors: Sandra M. Butler, Nicholas Pomato, Ebo Bos, Michael G. Hanna, Jr., Martin V. Haspel, Herbert C. Hoover, Jr.